Exhibit 3.1
BAUDAX BIO, INC.
CERTIFICATE OF DESIGNATION
OF
SERIES B PREFERRED STOCK
OF
BAUDAX BIO, INC.
SEPTEMBER 20, 2022
Baudax Bio, Inc., a corporation organized and existing under the laws of the Commonwealth of Pennsylvania (the “Corporation”), in accordance with the provisions of 1522(b), (c), and (d) of the Pennsylvania Business Corporation Law of 1988, as amended (the “PBCL”), does hereby certify:
The board of directors of the Corporation (the “Board of Directors”) in accordance with the Amended and Restated Articles of Incorporation of the Corporation, as amended (the “Articles of Incorporation”), and applicable law, adopted the following resolution by unanimous written consent on September 16, 2022 creating a series of 60,000 shares of preferred stock of the Corporation designated as “Series B Preferred Stock”.
WHEREAS, the Articles of Incorporation provide for a class of the Company’s authorized stock known as preferred stock, consisting of 10,000,000 shares, $0.01 par value per share, issuable from time to time in one or more series;
WHEREAS, the Board of Directors is authorized to fix the designations, powers, including voting powers, full or limited, or no voting powers, preferences and the relative, participating, optional or other special rights of the shares of each series and any qualifications, limitations and restrictions thereof;
WHEREAS, it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the designations, powers, restrictions and other matters relating to a series of the preferred stock, which shall consist of up to 60,000 shares of the Series B Preferred Stock which the Corporation has the authority to issue;
NOW, THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of the Series B Preferred Stock and does hereby fix and determine the rights, preferences, restrictions and other matters relating to such series of preferred stock as follows:
TERMS OF PREFERRED STOCK
1. | Designation, Amount and Par Value. The series of Preferred Stock created hereby shall be designated as the Series B Preferred Stock (the “Series B Preferred Stock”), and the number of shares so designated shall be 60,000. Each share of Series B Preferred Stock shall have a par value of $0.01 per share. |
2. | Dividends. The holders of Series B Preferred Stock, as such, shall not be entitled to receive dividends of any kind. |